| 000 | 01400 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515225134.0 | ||
| 264 | 0 | _c20100914 | |
| 008 | 201009s 0 0 eng d | ||
| 022 | _a1665-2681 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAl Ali, Jaber | |
| 245 | 0 | 0 |
_aPegylated interferon alfa-2b plus ribavirin for the treatment of chronic hepatitis C genotype 4 in adolescents. _h[electronic resource] |
| 260 |
_bAnnals of hepatology _c |
||
| 300 |
_a156-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 |
_aAntiviral Agents _xadverse effects |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdiagnosis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadverse effects |
| 650 | 0 | 4 | _aKuwait |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aPolyethylene Glycols _xadverse effects |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRibavirin _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aOwayed, Salem | |
| 700 | 1 | _aAl-Qabandi, Wafa'a | |
| 700 | 1 | _aHusain, Khaled | |
| 700 | 1 | _aHasan, Fuad | |
| 773 | 0 |
_tAnnals of hepatology _gvol. 9 _gno. 2 _gp. 156-60 |
|
| 999 |
_c19876554 _d19876554 |
||